Page last updated: 2024-09-21

4-nitroacetophenone

Description

4-nitroacetophenone : A member of the class of acetophenones that is acetophenone substituted at the para-position by a nitro group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7487
CHEMBL ID167997
CHEBI ID60546
CHEBI ID28735
SCHEMBL ID11922684
SCHEMBL ID27765
MeSH IDM0042398

Synonyms (79)

Synonym
MLS002152933
smr001224529
p-nitrophenyl methyl ketone
paranitroacetophenone
p-acetylnitrobenzene
ethanone, 1-(4-nitrophenyl)-
nsc41590
acetophenone, 4'-nitro-
nsc-41590
4'-nitroacetophenone
NCGC00091379-01
pnap
ccris 1676
nsc 41590
einecs 202-827-4
methyl-p-nitrophenyl ketone
ai3-19032
4-nitroacetophenone
C02803
p-nitroacetophenone
100-19-6
4'-nitroacetophenone, 98%
1-(4-nitrophenyl)ethanone
STK328124
AC-10991
CHEBI:60546 ,
p-nitrobenzoyl
4-(nitrophenyl)carbonyl
p-(nitrophenyl)carbonyl
CHEMBL167997
chebi:28735 ,
N0111
AKOS000118933
NCGC00091379-02
unii-4fm2j8hq27
4fm2j8hq27 ,
HMS3039I06
dtxcid105724
tox21_200265
cas-100-19-6
NCGC00257819-01
dtxsid1025724 ,
SCHEMBL11922684
1-(4-nitrophenyl)-ethanone
BBL010615
1-acetyl-4-nitrobenzene
FT-0689209
BP-13008
PS-4614
EPITOPE ID:138720
4-nitrophenylacetoaldehyde
4-acetylnitrobenzene
1-(4-nitrophenyl)ethan-1-one
AH-214/02411035
SCHEMBL27765
p-nitro-acetophenone
4-nitrophenyl methyl ketone
4nitro acetophenone
p-nitro acetophenone
4-nitro acetophenone
1-(4-nitro-phenyl)ethanone
1-(4-nitrophenyl)ethanone #
methyl 4-nitrophenyl ketone
CS-W020570
W-108972
nsc 41590; p-acetylnitrobenzene
F0001-0011
mfcd00007355
AC1233
para-nitroacetophenone
SY011156
4 inverted exclamation mark -nitroacetophenone
nitroacetophenone, p-
methyl p-nitrophenyl ketone
acetophenone, p-nitro-
1-(4-nitro-phenyl)-ethanone
Q27103872
EN300-19195
A936889

Drug Classes (2)

ClassDescription
acetophenonesA class or aromatic ketone consisting of acetophenone, PhC(=O)CH3, and its substituted derivatives.
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (11)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
interleukin 8Homo sapiens (human)Potency74.97800.047349.480674.9780AID651758
AR proteinHomo sapiens (human)Potency44.66840.000221.22318,912.5098AID588516
pregnane X nuclear receptorHomo sapiens (human)Potency54.53810.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency24.45820.000229.305416,493.5996AID1259244; AID743075
activating transcription factor 6Homo sapiens (human)Potency61.72020.143427.612159.8106AID1159516
mitogen-activated protein kinase 1Homo sapiens (human)Potency50.11870.039816.784239.8107AID995
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency74.97800.000627.21521,122.0200AID651741
gemininHomo sapiens (human)Potency23.10930.004611.374133.4983AID624296
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency48.60710.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency48.60710.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (18)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID200690Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID323693Activity of rat liver 3-alpha-HSD assessed as formation of corresponding (S)-alcohol products per mg of protein2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Electronic effects of para-substitution on acetophenones in the reaction of rat liver 3alpha-hydroxysteroid dehydrogenase.
AID323691Activity of rat liver 3-alpha-HSD assessed as formation of corresponding (S)-alcohol products2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Electronic effects of para-substitution on acetophenones in the reaction of rat liver 3alpha-hydroxysteroid dehydrogenase.
AID23442Partition coefficient (logP)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID323692Ratio of Vmax to Km for rat liver 3-alpha-HSD for formation of corresponding (S)-alcohol products2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Electronic effects of para-substitution on acetophenones in the reaction of rat liver 3alpha-hydroxysteroid dehydrogenase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (45.95)18.7374
1990's8 (21.62)18.2507
2000's3 (8.11)29.6817
2010's7 (18.92)24.3611
2020's2 (5.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]